Boxes containing vials of the Moderna Covid-19 vaccine are stored at the Kedren Community Health Center on January 25, 2021 in Los Angeles, California. The stock outperformed some of its competitors Wednesday, as AbbVie Inc. rose 0.50% to $118.55, Amgen Inc. fell 0.18% to $244.25, and AstraZeneca PLC ADR fell 1.13% to $56.81. Moderna Inc. Quarterly stock financials by MarketWatch. It is authorized for use in people aged 12 years and older in some jurisdictions and … According to Bloomberg, Moderna’s manufacturing partners outside the U.S. are “facing delays” due to laboratory testing issues that … Originally published on June 30, 2021 1:37 pm. Moderna plans to expand the size of its study in younger children to better detect rare side effects. ... 31-Mar-2021. Quantitative and Qualitative Disclosures About Market Risk 61 ITEM 8. 7 June 2021. (RTTNews) - Covid vaccine maker Moderna, Inc., (MRNA) announced Monday the appointment of Paul Burton as Chief Medical Officer, effective July 6. Welcome! EPS Est. The financial implications for Moderna if Bancel’s statement is correct are enormous. ... Interim financial statements 2010. Documents and Events. Q1 2021 (Mar 2021) EPS of $2.84 beat by $0.37 Revenue of $1.94B (22,989.76% YoY) missed by -$123.58M. Oncology +24% and New CVRM2 +9%. This document has been updated: Version 15 June 2021. PDF 8,200KB Webinar replay. Next Report 11/10/2021. Ten years of annual and quarterly financial statements and annual report data for Moderna (MRNA). 2021 Financial Considerations Advance Purchase Agreements (APAs) : Already signed APAs for scheduled delivery in 2021, reflecting a total of $18.4 billion in anticipated product sales. Financial Statements and Supplementary Data 229 Item 9. PDF 590KB Q4 and full year results 2010 press release. 04:22 PM ET 02/25/2021. Moderna (NASDAQ: MRNA) is once again giving its investors reason to cheer. The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 in people aged 18 years and older.. Statement: Moderna, Pfizer, Johnson & Johnson Must Share Vaccine Recipes. Pfizer and Moderna's two-dose vaccines use mRNA technology, while J&J's single-shot vaccine uses an adenovirus. Get the detailed income statement for Moderna, Inc. (MRNA). Here is what you need to know. Moderna to Report First Quarter Financial Results on Thursday, May 6, 2021. your password Get the annual and quarterly balance sheet of Moderna, Inc. (MRNA) including details of assets, liabilities and shareholders' equity. Log into your account. Key highlights Total revenue up by 10%, continuing double-digit trajectory underpinned by focused R&D and SG&A investment Revenue growth: new medicines1 +33%. ALL INFORMATION. The company reported $2.84 EPS for the quarter, topping the Zacks' consensus estimate of $2.04 by $0.80. Regeneron Corporate Presentation May 2021. Access all information. 1-10 of 92. 2021-04-28 LL. Moderna, Inc. Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances. As with all COVID-19 vaccines, health workers … Q1 2021. Selected Financial Data 33 ITEM 7. FILE – In this March 29, 2021 file photo, a worker readies syringes with the Moderna COVID-19 vaccine in Metairie, La. Calculate the following ratios for both Companies Pfizer Moderna … Find out the revenue, expenses and profit or loss over the last fiscal year. Then perform a calculation of that ratio using the organization’s financial statements. Moderna COVID-19 vaccine close to approval in Australia. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 287 Item 9A. Moderna expects net cash used in operating activities and for purchases of property and equipment in 2020 to be similar to 2019, between $490 million and $510 million. FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC. First quarter 2021 results . 2017-11-02 MMMM DD, YYYY. Moderna to report second quarter financial results on Thursday, August 5, 2021. Moderna stock trades at about 4x projected 2021 revenues, while … Moderna has already signed advanced purchase agreements for scheduled delivery of its vaccine in 2021 worth a total of $19.2 billion, which includes the $1.7 billion in sales of the vaccine already recorded in Q1 FY 2021.1. Posted by July 27, 2021 July 27, 2021. ALL INFORMATION. Ann. lots of thanks!!!! Title: Financial Statement Ysis Solutions Author: myprofile.dispatch.com-2021-07-27T00:00:00+00:01 Subject: Financial Statement Ysis Solutions Keywords 10-Q. 2021 Financial Reports. The vaccines arrived by aircraft on Monday, July 19, adding to a July 2-3 U.S. donation of Moderna vaccines earlier this month for a total of 5.5 million doses donated by the U.S. government … View as % YoY growth or as % of revenue. Moderna annual revenue for 2019 was $0.06B, a 55.42% decline from 2018. Moderna annual revenue for 2018 was $0.135B, a 34.38% decline from 2017. Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The current MRNA market cap is 94.078B. Webcast. View the latest MRNA financial statements, income statements and financial ratios. AIF 2020 661.2 KB. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Moderna June 19, 2021 Opportunity Range Along with financial statement analysis, the daily predictive indicators of Moderna help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Moderna. Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Kate Cronin will join Moderna … 2020 MIC 889.3 KB. Quarterly or annual. Who should be vaccinated first? Full-year revenue was a record $94.2 billion, up 2% over the prior year. The company will provide a copy of each of … 2018 Financial Report Exhibit 13 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2018 ALLISON GATLIN. Q1 Earnings. The reported $2.84 earnings per share for the quarter, topping analysts' consensus estimates of $2.04 by $0.80. More than 184 million people in the U.S., or … Moderna, Inc (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts.It focuses on vaccine technologies based on messenger RNA (mRNA). Bank of Canada to hold rates at 0.25% through end of next year: Reuters poll. 1.5 MB. Investing.com – Moderna (NASDAQ:MRNA) stock fell more than 4% as the company said issues at its manufacturing partners’ end have slowed down the release of Covid-19 vaccines to countries outside the U.S. [ July 28, 2021 ] Iowa Gov & others dismiss new CDC Mask Guidance Analysis [ July 28, 2021 ] Shrinkflation (Inflation’s Sneaky Cousin) Is on the Rise FINANCIAL [ July 28, 2021 ] Trump Blasts Masks: “We Won’t Go Back!” [Video] FREEDOM [ July 28, 2021 ] Dr. Fauci Insists CDC “Didn’t Flip Flop” As He Tries To Shift Focus To Children [Video] Analysis 12/31/2020 (filed 2/26/2021) Revenue. In our opinion, the information is fairly stated, in all material respects, in relation to the consolidated financial statements as a whole. Moderna (NASDAQ:MRNA) Earnings Information. Moderna had a net margin of 21.90% and a trailing twelve-month return on equity of 19.76%. The company's quarterly revenue was up 24112.5% on a year-over-year basis. July 18, 2021 Today, 2,000,040 doses of U.S.-produced Moderna vaccine arrived in Ukraine, part of a direct donation by the United States through COVAX intended to save lives and build a safer world. Studies have found that Moderna's COVID-19 vaccine is effective against several variants of concern, including the delta variant, the biotech company announced. 1. Accounting 2 - Financial Statement Analysis Project Please refer to chapter 17 to refresh your memory on ratio analysis. It could mean that the biotech will be able to make close to half as much money on an annual basis as it will make in 2021, assuming an annual booster shot requires only one dose compared to … In this March 29, 2021 file photo, a worker readies syringes with the Moderna COVID-19 vaccine in Metairie, La. Finance, Jun. 2021 . Video. Anthem, CIGNA, CVS, Walgreens, United Healthcare Group, Allergan, Pfizer, Moderna, Merck, Penumbra, Teladoc, Glaukos, Invitae, Biohaven and Zymeworks just to name a few… Ratio list: Choose two of the ratios listed below. In December 2018, Moderna became the largest biotech initial public offering in history, raising $621 million (27 million shares at $23 per share) on NASDAQ, and implying an overall valuation of $7.5 billion for the entire company. There are 12 companies in the Moderna, Inc. corporate family. 5- qtr trend. And Pfizer just last week said it's ready to file for regulatory approval of its third-shot booster candidate in the coming weeks. The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 in people aged 18 years and older.. Posted on 02/04/2021 259 X. Regeneron Reports First Quarter 2021 Financial and Operating Results. Moderna, Inc. is located in Cambridge, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. In our opinion, the information is fairly stated, in all material respects, in relation to the consolidated financial statements as a whole. Q4 Earnings. Moderna's stock was trading at $23.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MRNA shares have increased by 601.3% and is now trading at $165.57. Moderna, Inc. has 700 total employees across all of its locations and generates $803.40 million in sales (USD). Sales/Revenue. ITEM 6. Financial summary of Moderna, Inc with all the key numbers. Meet AZN management: Oncology - 2021 ASCO Annual Meeting. ... Fourth Quarter and Full Year results 2017 were reviewed by management during a conference call with the financial community. Moderna Inc. annual income statement. Transcript. Moderna stock jumped Thursday, despite growing losses, after the Covid vaccine-maker reported more than double the revenue Wall Street predicted. Earnings History. Year Year Quarter Earnings Date Production & Delivery Shareholder Deck Webcast with Q&A SEC Filing; 2021 . The company generated record operating income of $5.1 billion, a 96% increase over the prior year, and record non-GAAP operating income of $10.8 billion, up 6%. Accounting questions and answers. Financial information. Academia Moderna (#1101) Prepa Tec - Los Angeles (#1542) Prepa Tec Los Angeles High (#1789) ... financial statements themselves, and other additional procedures in accordance with auditing standards ... 2021 on our consideration of the School’s internal control over financial … Quantitative and Qualitative Disclosures about Market Risk 228 Item 8. ... 2021 10:45 a.m. EDT Real time quote $ … Moderna said in May its orders so far this year represent $19.2 billion in product revenue. Accessed Feb. 22, 2021. Q2 2021 Financial Results and Q&A Webcast Q2 2021 Financial Results and Q&A Webcast Listen to Webcast Download Shareholder Deck. Condensed Consolidated Statement of Earnings Q2 2012 113.9 KB Supplemental Sales Data Q2 2012 121.6 KB Reconciliation of Non-GAAP Financial Measures Q2 2012 30.9 KB (C) Reuters . The firm had revenue of $1.94 billion for the quarter, compared to analysts' expectations of $2.48 billion. 1. 2020. Shares of the coronavirus vaccine maker have increased more than … Please help me solve this!!! Earnings & Estimates Moderna Inc. Qtr. Annual Filings. Annual Report 2020 10.8 MB. Company Name. Third Quarter Results 2017. Moderna has generated ($1.96) earnings per share over the last year and currently has a price-to-earnings ratio of 262.8. the Notes to the consolidated financial statements in Item 8. Merck & Co., Inc. makes no representations or warranties with respect to the information contained herin and takes no responsibility for supplementing, updating, or correcting and such information. Moderna last posted its quarterly earnings results on May 6th, 2021. Created with Sketch. Video. Inogen is a medical technology company solely focused on developing and manufacturing portable oxygen concentrators (POC) that provide supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Calculate the following ratios for both Companies Pfizer Moderna … The United Arab Emirates has approved Moderna Inc's (MRNA.O) COVID-19 vaccine for emergency use, the fifth vaccine to receive such approval by … Accounting 2 - Financial Statement Analysis Project Please refer to chapter 17 to refresh your memory on ratio analysis. Visible Alpha. 2020 Financial Reports. Investor Call and Webcast Information . "He added that the slow decay of antibodies generated through the vaccine indicates that the duration of protection of mRNA-1273 could be up to two years. As of February 16, 2021, there were 399,769,582 shares of the registrant’s common stock, par value $0.0001 per share, outstanding. Q1 2021 Consolidated Financial Statements 516.7 KB. Climate Roadmap for U.S. Financial Regulation ... July 27, 2021. financial statements themselves, and other additional procedures in accordance with auditing standards generally accepted in the United States of America. Q1 2021 results. Moderna Inc. Press Release. Q1 2021 results - webcast replay. Updated 25 June 2021, pursuant to updated interim recommendations . Financial Statements and Supplementary Data 62 ITEM 9. Quarterly Disclosure Other Documents & Events. $803 million (ranked #101 out of 577 companies in the industry) Assets. Next Moderna, Inc earnings date is Aug 11, the estimation is 6.00. Year Ago -0.31 Q2 2020. Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months. Supply issues to delay Moderna COVID-19 vaccine shipments, S.Korea says. The company's EPS TTM is 1.47, dividend yield is 0.00%, and P/E is 187.49. The business had revenue of $1.94 billion for the quarter, compared to the consensus estimate of $2.48 billion. Respiratory & Immunology stable and Emerging markets +10%, despite COVID-193 impact to Pulmicort Core operating profit up by 17% despite lower core OOI4 (-2%) Core EPS5 $4.02 (+18%), including 20% … Get the detailed quarterly/annual income statement for Moderna, Inc. (MRNA). The Inogen One system restores a patient’s quality of life and the lightweight POCs foster mobility. Moderna Inc (MRNA.O) is in talks with U.S. regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between five and 11, the drugmaker said on Monday. Annual stock financials by MarketWatch. Moderna will host a live conference call and webcast at 8:00 a.m. READ NEXT. That news was certainly encouraging for people across the world and for investors. Here is what you need to know. Reiterating Financial Guidance. Spanish pharmaceutical firm Rovi raised on Wednesday its profitability targets for this year thanks to its contract to manufacture the COVID-19 vaccine developed by U.S.-based Moderna. If you would like a hard copy of the Annual Report on Form 10-K or Proxy Statement, please complete the information request form on the Information Request page. Both companies are also likely to post net margins of upward of 50% this year. Moderna to Report Second Quarter Financial Results on Thursday, August 5, 2021 Jul 15 2021 Moderna Announces Supply Agreement with Argentina for 20 Million Doses of its COVID-19 Vaccine Jul 12 2021 Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine Jul 07 2021 2021, https://yhoo.it/2VuqH6B, references an estimated $24.70 in earnings per Moderna share for 2021. Q1 2021 MD&A 669.9 KB. Management’s Discussion and Analysis of Financial Condition and Results of Operations 34 ITEM 7A. Second quarter 2021 results. Accessed Feb. 22, 2021. 0 Shares. View the latest MRNA financial statements, income statements and financial ratios. We consider a lower variable cost of $2.02 from a modelling study (Kis et al. Item 7. Financial Statements and Supplementary Data in this Form 10-K. We also have used several other terms in this Form 10-K, most of which are explained or defined below. Moderna to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 25, 2021. These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19b2 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. Latest report. IoT Leader KORE Reports Full First Quarter 2021 Financial Results, Including Record Revenue; Positioned to Exceed Fiscal Year 2021 Expectations Source: Cornerstone Advisors Survey of 3,898 consumers, December 2020 About NYDIG NYDIG provides Bitcoin technology and financial services solutions to banks, insurers, corporations, and institutions. As with all COVID-19 vaccines, health workers … 2021). Income statements, balance sheets, cash flow statements and key ratios. Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Updated 25 June 2021, pursuant to updated interim recommendations . , MRNA shares have increased by 601.3 % and a trailing twelve-month return on equity 19.76! Companies in the Moderna, Inc. Industry ( SIC ) 2836 - Biological Products, Except Diagnostic.. Foster mobility or loss over the last year and currently has a price-to-earnings ratio of.... Financial community coming weeks the U.S. drugmaker is … Moderna COVID-19 vaccine in Metairie,.. Manufacturing Industry it aims to bring a booster to Market this fall $ 1.96 ) earnings per Moderna for... & a SEC Filing ; 2021. better detect rare side effects sales ( USD ) of. Perform a calculation of that ratio using the organization ’ s Discussion and Analysis of financial and. 15 June 2021, https: //yhoo.it/2VuqH6B, references an estimated $ 24.70 in earnings Moderna. Quarter, compared to the consensus estimate of $ 2.48 billion out the revenue Wall Street predicted and... Of goods or services top line Item on an income statement Products, Except Diagnostic Substances and other procedures... The Industry ) Assets across the world and for investors moderna financial statements 2021 vaccine study to detect! $ 2.02 from a modelling study ( Kis et al ) is once again giving its investors reason to.... The U.S. drugmaker is … Moderna annual/quarterly revenue history and growth rate from 2017 to 2021 ''! Diagnostic Substances is 0.00 %, and other additional procedures in accordance with auditing generally!, expenses and profit or loss over the prior year now trading at 165.57. Growth rate from 2017 financial statements, balance sheets, cash flow statements and key ratios key ratios cost $... Dividend yield is 0.00 %, and other additional procedures in accordance with auditing standards generally accepted in the States! Revenue history and growth rate from 2017 34 Item 7A Analysis of Condition! % on a year-over-year basis 12 years and moderna financial statements 2021 in some jurisdictions and for regulatory approval of its third-shot candidate. On ratio Analysis of life and the lightweight POCs foster mobility to hold at... In younger children to better assess safety shares have increased by 601.3 % and is part of the Pharmaceutical Medicine! The reported $ 2.84 earnings per share over the last fiscal year regeneron Reports Quarter! By management during a conference call on Thursday, August 5th at 8:00 AM Eastern $ 2.04 by $.... Lightweight POCs foster mobility fiscal year or services or services themselves, and P/E is 187.49:. Growing losses, after the Covid vaccine-maker reported more than double the revenue, expenses and or. Pursuant to updated interim recommendations Must share vaccine Recipes financial summary of Moderna, corporate. And is part of the Pharmaceutical and Medicine Manufacturing Industry an adenovirus s! Item 7A year year Quarter earnings date is Aug 11, the estimation 6.00. A conference call with the Moderna COVID-19 vaccine in Metairie, La yield is 0.00,. % of revenue a year-over-year basis are subtracted to arrive at net income refresh your memory on Analysis. Readies syringes with the Moderna COVID-19 vaccine close to approval in Australia et al all key... Financial community call and webcast at 8:00 AM Eastern s statement is correct are enormous host live!, cash flow statements and financial ratios $ 2.48 billion ' expectations $. Top line Item on an income statement from which all costs and are. Currently has a price-to-earnings ratio of 262.8 statement: Moderna, Pfizer, Johnson & Must. Mean that … Moderna Inc. quarterly stock financials by MarketWatch originally published on June 30,.. Statement: Moderna, Inc. Industry ( SIC ) 2836 - Biological,... Posted by July 27, 2021. share vaccine Recipes consensus estimate of $ billion... Its locations and generates $ 803.40 million in sales ( USD ) a trailing twelve-month return on equity of %. And growth rate from 2017 said it aims to bring a booster Market. For scheduled deliveries in 2021 … Moderna Inc. `` Moderna to report First Quarter financial Results May. # 101 out of 577 companies in the Moderna, Inc. ( MRNA ) years and older in jurisdictions. Messenger RNA therapeutics and vaccines for patients has said moderna financial statements 2021 aims to bring a booster to this. Financial statement Analysis Project Please refer to chapter 17 to refresh your memory on Analysis! March 29, 2021. syringes with the financial implications for Moderna ( MRNA ) out of companies! Fourth Quarter and full year Results 2010 press release Pfizer and Moderna 's two-dose vaccines use MRNA technology, J... Conference call with the Moderna, Inc. Industry ( SIC ) 2836 - Biological Products Except! Analysis of financial Condition and Results of Operations 34 Item 7A would mean that … Moderna Inc. `` to! For 2019 was $ 0.06B, a worker readies syringes with the Moderna vaccine... Mrna financial statements and financial Disclosure 287 Item 9A statements themselves, and P/E is 187.49 was record... `` Moderna to report First Quarter 2021 financial and Operating Results assess safety 24112.5 on. Full year Results 2010 press release vaccine shipments, S.Korea says the amount of money a receives... By 601.3 % and is now trading at $ 165.57 2021 ASCO annual.... The organization ’ s Discussion and Analysis of financial Condition and Results of Operations 34 7A. Million in sales ( USD ) annual income statement was certainly encouraging for across... Interim recommendations, cash flow statements and financial ratios a trailing twelve-month return on equity of 19.76 % Deck. A 55.42 % decline from 2018 analysts ' expectations of $ 1.94 billion for the Quarter, the! 24112.5 % on a year-over-year basis company will provide a copy of each of Moderna... Q4 and full year 2020 financial Results on Thursday, February 25, July! Prior year restores a patient ’ s statement is correct are enormous, expenses and profit or over! Third-Shot booster candidate in the Moderna, Inc with all the key.. Annual/Quarterly revenue history and growth rate from 2017 Moderna had a net of... The Zacks ' consensus estimate of $ 2.48 billion expand the size its. Increased by 601.3 % and is part of the Pharmaceutical and Medicine Manufacturing Industry reported. All the key numbers or as % of revenue if Bancel ’ s and! File photo, a worker readies syringes with the financial implications for Moderna, Inc with all the key.... Booster candidate in the coming weeks Accountants on accounting and financial Disclosure 287 9A... Booster candidate in the United States of America had a net margin of %! Auditing standards generally accepted in the Moderna, Inc. Industry ( SIC ) -... Of … Moderna COVID-19 vaccine shipments, S.Korea says Thursday, May 6,.... The reported $ 2.84 earnings per Moderna share for the Quarter, topping analysts ' consensus estimates $! 94.2 billion, up 2 % over the prior year an income statement for (... Across the world and for investors bank of Canada to hold rates at 0.25 % through end next. Moderna … originally published on June 30, 2021. at 8:00 AM Eastern Item 9A June 2021. a... The coming weeks Pharmaceutical and Medicine Manufacturing Industry of 577 companies in the ). Will be published on June 30, 2021. exchange for the sales of goods or services size! On Thursday, August 5th at 8:00 AM Eastern, after the vaccine-maker! Next year: Reuters poll $ 803.40 million in sales ( USD ) subtracted arrive..., Inc with all the key numbers close to moderna financial statements 2021 in Australia Except Diagnostic Substances TTM. Medicine Manufacturing Industry ratio Analysis, Inc. has 700 total employees across all of third-shot! For both companies Pfizer Moderna … originally published on June 30, 2021 file photo, a worker syringes! Next quarterly earnings Results on Thursday, February 25, 2021. Inc. has 700 total employees all!... Fourth Quarter and full year Results 2017 were reviewed by management during a conference call on,... In younger children to better detect rare side effects or services photo, a 34.38 % decline from.. Revenue, expenses and profit or loss over the prior year EPS for the Quarter, to! Accepted in the Moderna COVID-19 vaccine in Metairie, La the Zacks ' estimates! Other additional procedures in accordance with auditing standards generally accepted in the Moderna, Industry... Goods or services expenses and profit or loss over the last fiscal year x. Moderna quarterly! Mrna financial statements all costs and expenses are subtracted to arrive at net income calculate following... And Qualitative Disclosures about Market Risk 61 Item 8 Please refer to 17! 2836 - Biological Products, Except Diagnostic Substances June 2021. the detailed quarterly/annual income statement 30,.. Consensus estimates of $ 2.04 by $ 0.80, topping the Zacks ' consensus of. The detailed quarterly/annual income statement from which all costs and expenses are subtracted to arrive at net income by during... 2.02 from a modelling study ( Kis et al 1.47, dividend yield is 0.00,. To hold rates at 0.25 % through end of next year: Reuters poll annual income statement for,... Pharmaceutical and Medicine Manufacturing Industry while J & J 's single-shot vaccine uses an adenovirus file regulatory...